Rezolute announces positive data from its phase 2b (rize) study of rz358 in patients with congenital hyperinsulinism

Results presented today at the pediatric endocrine society's 2022 annual meeting results presented today at the pediatric endocrine society's 2022 annual meeting

RZLT Ratings Summary

RZLT Quant Ranking